{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:17:30Z","timestamp":1789564650841,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30973529"],"award-info":[{"award-number":["30973529"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270278"],"award-info":[{"award-number":["81270278"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Drug Innovative Program","award":["11431920103"],"award-info":[{"award-number":["11431920103"]}]},{"name":"Program for Professor of Special Appointment (Eastern Scholar)"}],"content-domain":{"domain":["thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.thromres.2014.07.019","type":"journal-article","created":{"date-parts":[[2014,7,17]],"date-time":"2014-07-17T07:32:13Z","timestamp":1405582333000},"page":"866-876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Salvianolic acid B inhibits platelets as a P2Y12 antagonist and PDE inhibitor: Evidence from clinic to laboratory"],"prefix":"10.1016","volume":"134","author":[{"given":"Lei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satya P.","family":"Kunapuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongren","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2014.07.019_bb0005","doi-asserted-by":"crossref","first-page":"s33","DOI":"10.1161\/ATVBAHA.107.160689","article-title":"P2Y12 antagonism: promises and challenges","volume":"28","author":"Michelson","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2014.07.019_bb0010","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1161\/CIRCULATIONAHA.108.822791","article-title":"Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"119","author":"Chen","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2014.07.019_bb0015","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jacc.2010.10.035","volume":"57","author":"Lee","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2014.07.019_bb0020","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jacc.2010.08.631","volume":"57","author":"Suh","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2014.07.019_bb0025","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.jacc.2005.07.048","article-title":"Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis","volume":"46","author":"Lee","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2014.07.019_bb0030","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1002\/rcm.1703","article-title":"Simultaneous determination of magnesium lithospermate B, rosmarinic acid, and lithospermic acid in beagle dog serum by liquid chromatography\/tandem mass spectrometry","volume":"18","author":"Li","year":"2004","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.thromres.2014.07.019_bb0035","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/j.1538-7836.2010.03859.x","article-title":"Salvianolic acid A inhibits platelet activation and arterial thrombosis via inhibition of phosphoinositide 3-kinase","volume":"8","author":"Huang","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.07.019_bb0040","doi-asserted-by":"crossref","first-page":"e14692","DOI":"10.1371\/journal.pone.0014692","article-title":"Differential proteomic analysis of platelets suggested possible signal cascades network in platelets treated with salvianolic acid B","volume":"6","author":"Ma","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2014.07.019_bb0045","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1161\/CIRCULATIONAHA.107.181940","volume":"116","author":"Anderson","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2014.07.019_bb0050","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0049-3848(03)00377-3","article-title":"Flow cytometric analysis of platelet activation in hypertensive patients. Effect of doxazosin","volume":"110","author":"Labios","year":"2003","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2014.07.019_bb0055","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1160\/TH11-06-0400","article-title":"BF061, a novel antiplatelet and antithrombotic agent targeting P2Y(1)(2) receptor and phosphodiesterase","volume":"106","author":"Hu","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.07.019_bb0060","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1160\/TH10-05-0285","article-title":"BF0801, a novel adenine derivative, inhibits platelet activation via phosphodiesterase inhibition and P2Y12 antagonism","volume":"104","author":"Zhang","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.07.019_bb0065","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1111\/jth.12362","article-title":"Tumor vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid inhibits platelet activation and thrombosis via inhibition of thromboxane A2 signaling and phosphodiesterase","volume":"11","author":"Zhang","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.07.019_bb0070","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1182\/blood-2004-01-0069","article-title":"Role of G protein-gated inwardly rectifying potassium channels in P2Y12 receptor-mediated platelet functional responses","volume":"104","author":"Shankar","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.07.019_bb0075","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/bj2690513","article-title":"Use of fluo-3 to measure cytosolic Ca2+ in platelets and neutrophils. Loading cells with the dye, calibration of traces, measurements in the presence of plasma, and buffering of cytosolic Ca2+","volume":"269","author":"Merritt","year":"1990","journal-title":"Biochem J"},{"key":"10.1016\/j.thromres.2014.07.019_bb0080","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1253\/circj.CJ-08-0289","article-title":"Evaluation of the antiplatelet effects of cilostazol, a phosphodiesterase 3 inhibitor, by VASP phosphorylation and platelet aggregation","volume":"72","author":"Yamamoto","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.thromres.2014.07.019_bb0085","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1042\/BJ20050796","article-title":"Vasodilator-stimulated phosphoprotein (VASP) is phosphorylated on Ser157 by protein kinase C-dependent and -independent mechanisms in thrombin-stimulated human platelets","volume":"393","author":"Wentworth","year":"2006","journal-title":"Biochem J"},{"key":"10.1016\/j.thromres.2014.07.019_bb0090","doi-asserted-by":"crossref","first-page":"e52146","DOI":"10.1371\/journal.pone.0052146","article-title":"Early mixed farming of millet and rice 7800years ago in the Middle Yellow River region, China","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2014.07.019_bb0095","first-page":"649","article-title":"Induction of platelet activation by cobra venom factor from Naja naja atra in rat","volume":"21","author":"Ding","year":"2000","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.thromres.2014.07.019_bb0100","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0003-2697(91)90454-2","article-title":"A reverse-phase HPLC method for cAMP phosphodiesterase activity","volume":"196","author":"Spoto","year":"1991","journal-title":"Anal Biochem"},{"key":"10.1016\/j.thromres.2014.07.019_bb0105","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1182\/blood-2007-09-110437","article-title":"RGT, a synthetic peptide corresponding to the integrin beta 3 cytoplasmic C-terminal sequence, selectively inhibits outside-in signaling in human platelets by disrupting the interaction of integrin alpha IIb beta 3 with Src kinase","volume":"112","author":"Su","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.07.019_bb0110","doi-asserted-by":"crossref","first-page":"e40451","DOI":"10.1371\/journal.pone.0040451","article-title":"BF066, a novel dual target antiplatelet agent without significant bleeding","volume":"7","author":"Pan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2014.07.019_bb0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijpharm.2006.07.003","article-title":"Bioavailability of salvianolic acid B in conscious and freely moving rats","volume":"326","author":"Wu","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1016\/j.thromres.2014.07.019_bb0120","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI20986","article-title":"Central role of the P2Y12 receptor in platelet activation","volume":"113","author":"Dorsam","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.thromres.2014.07.019_bb0125","doi-asserted-by":"crossref","first-page":"8070","DOI":"10.1073\/pnas.95.14.8070","article-title":"Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation","volume":"95","author":"Jin","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.thromres.2014.07.019_bb0130","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1161\/01.ATV.0000145980.39477.a9","article-title":"Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance","volume":"24","author":"Cattaneo","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2014.07.019_bb0135","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1182\/asheducation-2011.1.70","article-title":"The clinical relevance of response variability to antiplatelet therapy","volume":"2011","author":"Cattaneo","year":"2011","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.thromres.2014.07.019_bb0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1538-7836.2004.01063.x","article-title":"Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases","volume":"3","author":"Aleil","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.07.019_bb0145","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1046\/j.1365-2141.2000.02208.x","article-title":"The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity","volume":"110","author":"Storey","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2014.07.019_bb0150","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.amjcard.2010.08.026","article-title":"Antiplatelet therapy in acute coronary syndrome (ACS): applying new science to clinical decisions","volume":"106","author":"Becker","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.thromres.2014.07.019_bb0155","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.2165\/11594100-000000000-00000","article-title":"Triple antiplatelet therapy in acute coronary syndromes","volume":"71","author":"Valgimigli","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.thromres.2014.07.019_bb0160","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0955-0674(94)90096-5","article-title":"Adhesive signaling in platelets","volume":"6","author":"Shattil","year":"1994","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.thromres.2014.07.019_bb0165","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.thromres.2008.05.020","article-title":"Salvianolic acid B inhibits platelet adhesion under conditions of flow by a mechanism involving the collagen receptor alpha2beta1","volume":"123","author":"Wu","year":"2008","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2014.07.019_bb0170","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1142\/S0192415X08005795","article-title":"Interaction of salvianolic acids and notoginsengnosides in inhibition of ADP-induced platelet aggregation","volume":"36","author":"Yao","year":"2008","journal-title":"Am J Chin Med"},{"key":"10.1016\/j.thromres.2014.07.019_bb0175","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1124\/dmd.106.013045","article-title":"Pharmacokinetics, tissue distribution, metabolism, and excretion of depside salts from Salvia miltiorrhiza in rats","volume":"35","author":"Li","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.thromres.2014.07.019_bb0180","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-0038-1657286","article-title":"The effect of a medicinal Chinese herb on platelet function","volume":"48","author":"Wang","year":"1982","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.07.019_bb0185","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000338812","article-title":"Cilostazol-based triple antiplatelet therapy compared to dual antiplatelet therapy in patients with coronary stent implantation: a meta-analysis of 5,821 patients","volume":"122","author":"Geng","year":"2012","journal-title":"Cardiology"},{"key":"10.1016\/j.thromres.2014.07.019_bb0190","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2125.2009.03402.x","article-title":"Triple antiplatelet therapy vs. dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: an evidence-based approach to answering a clinical query","volume":"68","author":"Singh","year":"2009","journal-title":"Br J Clin Pharmacol"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814003946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814003946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T10:12:40Z","timestamp":1649671960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384814003946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0049384814003946"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2014.07.019","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salvianolic acid B inhibits platelets as a P2Y12 antagonist and PDE inhibitor: Evidence from clinic to laboratory","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2014.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}